FERRO CORP (FOE)

US3154051003 - Common Stock

22.01  +0.06 (+0.27%)

After market: 22.01 0 (0%)

Fundamental Rating

2

FOE gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 84 industry peers in the Chemicals industry. FOE has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, FOE is valued expensive at the moment.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

FOE had positive earnings in the past year.
FOE had positive earnings in each of the past 5 years.
In multiple years FOE reported negative operating cash flow during the last 5 years.

1.2 Ratios

Industry RankSector Rank
ROA 11.54%
ROE 27.65%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 11.26%
PM (TTM) 13.22%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

2

2. Health

2.1 Basic Checks

FOE has more shares outstanding than it did 1 year ago.
The debt/assets ratio for FOE has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 3.42 indicates that FOE is not in any danger for bankruptcy at the moment.
FOE has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF N/A
Altman-Z 3.42
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 1.77 indicates that FOE should not have too much problems paying its short term obligations.
FOE has a Quick Ratio of 1.77. This is a bad value and indicates that FOE is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 0.91

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 53.66% over the past year.
The Earnings Per Share has been growing slightly by 2.75% on average over the past years.
FOE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.45%.
Measured over the past years, FOE shows a decrease in Revenue. The Revenue has been decreasing by -0.33% on average per year.
EPS 1Y (TTM)53.66%
EPS 3Y-5.65%
EPS 5Y2.75%
EPS growth Q2Q20%
Revenue 1Y (TTM)17.45%
Revenue growth 3Y1.57%
Revenue growth 5Y-0.33%
Revenue growth Q2Q2.44%

3.2 Future

The Earnings Per Share is expected to grow by 6.16% on average over the next years.
The Revenue is expected to grow by 3.15% on average over the next years.
EPS Next Y-3.81%
EPS Next 2Y5.93%
EPS Next 3Y5.91%
EPS Next 5Y6.16%
Revenue Next Year3.86%
Revenue Next 2Y3.41%
Revenue Next 3Y3.07%
Revenue Next 5Y3.15%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

FOE is valuated rather expensively with a Price/Earnings ratio of 17.47.
The average S&P500 Price/Earnings ratio is at 28.02. FOE is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 18.16, the valuation of FOE can be described as rather expensive.
The average S&P500 Price/Forward Earnings ratio is at 20.58. FOE is around the same levels.
Industry RankSector Rank
PE 17.47
Fwd PE 18.16

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)6.34
EPS Next 2Y5.93%
EPS Next 3Y5.91%

More info and screens

0

5. Dividend

5.1 Amount

FOE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FERRO CORP

NYSE:FOE (4/21/2022, 7:04:00 PM)

After market: 22.01 0 (0%)

22.01

+0.06 (+0.27%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.84B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 17.47
Fwd PE 18.16
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)6.34
Profitability
Industry RankSector Rank
ROA 11.54%
ROE 27.65%
ROCE
ROIC
ROICexc
ROICexgc
OM 11.26%
PM (TTM) 13.22%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.77
Quick Ratio 0.91
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)53.66%
EPS 3Y-5.65%
EPS 5Y
EPS growth Q2Q
EPS Next Y-3.81%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)17.45%
Revenue growth 3Y1.57%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y